LINCOLN PHARMACEUTICALS LTD. | Scrip Code : 531633 | Quarter ending :March 2018 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 32 | 64,28,979 | 64,28,979 | 32.14 | 64,28,979 | 32.14 | 8,00,000 | 12.44 | 64,28,979 | - | - | - | (B) Public | 13,601 | 1,35,71,021 | 1,35,71,021 | 67.86 | 1,35,71,021 | 67.86 | | 0.00 | 1,34,07,311 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 13,633 | 2,00,00,000 | 2,00,00,000 | 100.00 | 2,00,00,000 | 100.00 | 8,00,000 | 4.00 | 1,98,36,290 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|